Beck Bode’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$283K Buy
4,374
+350
+9% +$25.5K 0.04% 81
2026
Q2
$328K Buy
+4,024
New +$291K 0.05% 79

Other funds holding PTCT

Beck Bode's PTCT Position: Q3 2026 in Review

Beck Bode increased its PTC Therapeutics (PTCT) stake by 8.7% in Q3 2026, buying an estimated $25.5K and bringing the position to 4,374 shares worth $283K. The position accounts for 0.04% of the portfolio, ranked #81.

Beck Bode first reported a position in PTCT in Q2 2026 and has held it in 2 quarters since. The position peaked at $328K in Q2 2026. 275 funds tracked by Wall St. Rank hold PTCT as of Q3 2026.

  • Beck Bode held 4,374 shares of PTC Therapeutics worth $283K as of Q3 2026.
  • Beck Bode bought 350 PTC Therapeutics shares in Q3 2026, an estimated $25.5K.
  • PTC Therapeutics made up 0.04% of Beck Bode's portfolio in Q3 2026, its #81 holding.
  • Beck Bode first reported a position in PTC Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Beck Bode's PTC Therapeutics position peaked at $328K in Q2 2026.
  • 275 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2026.

Based on Beck Bode's 13F filing for Q3 2026, filed 12 Nov 2026.